0001225208-13-025231.txt : 20131211 0001225208-13-025231.hdr.sgml : 20131211 20131211182850 ACCESSION NUMBER: 0001225208-13-025231 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131209 FILED AS OF DATE: 20131211 DATE AS OF CHANGE: 20131211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEILAND JOHN H CENTRAL INDEX KEY: 0001204663 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 131272035 MAIL ADDRESS: STREET 1: C/O C.R BARD INC STREET 2: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2013-12-09 0000009892 BARD C R INC /NJ/ BCR 0001204663 WEILAND JOHN H C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 1 President and COO Common Stock 2013-12-09 4 F 0 10062.0000 137.6800 D 134383.2900 D Common Stock 2013-12-10 4 S 0 1900.0000 137.8953 D 132483.2900 D Common Stock 2013-12-10 4 S 0 8489.0000 137.1615 D 123994.2900 D Common Stock 5573.5030 I 401(k) Plan Shares withheld to pay taxes upon vesting of restricted stock granted under the Company's 2003 Long Term Incentive Plan. Sales are pursuant to a previously disclosed 10b5-1 plan. Represents the weighted average sales price for price increments ranging from $137.85 to $137.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $136.80 to $137.76. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 5.358 shares acquired under the Company's 401(k) Plan from August 13, 2013 to December 9, 2013. Myra McGinley, Attorney-in-Fact 2013-12-11